ATAI Life Sciences NV (ATAI)
1.52
-0.07
(-4.40%)
USD |
NASDAQ |
Nov 21, 16:00
1.52
0.00 (0.00%)
After-Hours: 05:56
ATAI Life Sciences Debt to Equity Ratio: 0.1561 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1561 |
| June 30, 2024 | 0.1105 |
| March 31, 2024 | 0.0883 |
| December 31, 2023 | 0.0736 |
| September 30, 2023 | 0.0577 |
| June 30, 2023 | 0.0719 |
| March 31, 2023 | 0.0642 |
| December 31, 2022 | 0.058 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.0518 |
| June 30, 2022 | 0.002 |
| March 31, 2022 | 0.0021 |
| December 31, 2021 | 0.002 |
| September 30, 2021 | 0.0018 |
| June 30, 2021 | 0.0026 |
| March 31, 2021 | 0.0266 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0018
Minimum
Sep 2021
0.1561
Maximum
Sep 2024
0.0513
Average
0.0577
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.469 |
| InflaRx NV | 0.00 |
| BioNTech SE | 0.0127 |
| Immatics NV | 0.00 |
| CureVac NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 197.52M |
| Total Liabilities (Quarterly) | 51.20M |
| Shareholders Equity (Quarterly) | 145.72M |
| Current Ratio | 5.807 |
| Net Debt Paydown Yield | -0.77% |